pros and cons of glp-1 agonist glp 1 agonists The Medications for Weight Optimization Are Weight Loss Medications Right – pros and cons of glp

For instance, in January 2025, the FDA approved semaglutide (Ozempic) as a medication to reduce the risk of kidney failure, kidney disease progression, and cardiovascular death in adults with type 2 diabetes and chronic kidney disease (CKD)

PantaziACBalasaALMihaiCMChisnoiuTLupuVVKassimMAKet al

There are a handful of adverse outcomes that can result from excess vitamin D, including: Hypervitaminosis D: Although vitamin D toxicity is rare, its usually caused by megadosing

doi: 10.3389/fnut.2025.1566498 Received 24 January 2025 Accepted 28 March 2025 Published 25 April 2025 Volume 12 - 2025 Edited by Iolanda Cioffi, University of Milan, Italy Reviewed by Valentina Ponzo, University of Turin, Italy Emily Fritz, Consultant, South Barrington, IL, United States Alissa Smethers, Temple University, United States Updates Copyright 2025 Johnson, Milstead, Thomas, McGlasson, Green, Kreider and Jones